This is the authors' abstract. We don't add key points for this paper.
Supplementary Figure 1. AHCYL1 is selectively critical for NRAS-mutated but not for BRAF-mutated human melanoma cells.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Cai et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: